Related Experiment Videos
Acinetobacter peritonitis during chronic peritoneal dialysis
1Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0364.
Abstract:
Among gram-negative bacilli isolated during peritonitis in chronic peritoneal dialysis (CPD), Pseudomonas species are most common but Acinetobacter species are nearly as frequent. A survey of more than 450 patient-years' experience with CPD revealed 23 episodes of Acinetobacter peritonitis (AP), making this the second most common form of gram-negative peritonitis. Concomitant break in sterile technique and exit-site/tunnel infection were infrequent. AP appeared as the first peritonitis episode in five cases and as the second in six cases, and the duration of CPD at the time of AP ranged from less than 1 to greater than 56 months. However, AP was noted to appear shortly after treatment of another peritonitis episode or shortly after CPD access placement, within 2 months in 11 cases (47%) and within 3 months in 14 cases (61%). Treatment with intraperitoneal antibiotics succeeded in 21 cases (91%) without CPD interruption or catheter removal, with tobramycin or gentamicin alone in 16 cases, and with combined aminoglycoside and penicillin or cephalosporin in six cases. In two cases intraperitoneal antibiotics alone were insufficient therapy: one case with concomitant tunnel infection and dialysate leak and one case with bacteremia while receiving corticosteroids. The time-dependent incidence of AP suggests opportunistic infection during a vulnerable period in the first 2 to 3 months following another peritonitis episode, but AP also appears amenable to intraperitoneal antibiotic therapy alone without interruption of the CPD routine in the majority of cases.
Insights
Acinetobacter peritonitis is a common complication in chronic peritoneal dialysis (CPD). Intraperitoneal antibiotics are effective in most cases, often without needing to stop dialysis.
Area of Science:
- Nephrology
- Infectious Diseases
Background:
- Pseudomonas species are the most common gram-negative bacilli in chronic peritoneal dialysis (CPD) peritonitis.
- Acinetobacter species are nearly as frequent, representing the second most common gram-negative peritonitis.
Purpose of the Study:
- To investigate the incidence, timing, and treatment outcomes of Acinetobacter peritonitis (AP) in patients undergoing CPD.
- To determine if AP can be treated effectively without interrupting CPD or removing the catheter.
Main Methods:
- Retrospective survey of over 450 patient-years of CPD experience.
- Analysis of 23 episodes of Acinetobacter peritonitis.
- Review of treatment protocols and outcomes, including antibiotic regimens and need for catheter removal or CPD interruption.
Main Results:
- Acinetobacter peritonitis occurred in 23 episodes, often within 2-3 months after another peritonitis episode or CPD access placement.
- Intraperitoneal antibiotics were successful in 91% of cases (21/23), with 16 cases treated with aminoglycosides alone.
- CPD interruption or catheter removal was not required in most successful treatments.
Conclusions:
- Acinetobacter peritonitis is a significant concern in CPD patients, with a tendency for opportunistic infection following other peritonitis episodes.
- Intraperitoneal antibiotic therapy is highly effective for AP, allowing for continued CPD in the majority of patients.